Sarepta Therapeutics Inc (SRPT)
135.04
+1.38
(+1.03%)
USD |
NASDAQ |
May 06, 16:00
134.49
-0.55
(-0.41%)
Pre-Market: 08:05
Sarepta Therapeutics Price: 135.04 for May 6, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 06, 2024 | 133.60 | 135.16 | 132.62 | 135.04 | 528260.0 |
| May 03, 2024 | 132.55 | 134.46 | 131.16 | 133.66 | 1.196M |
| May 02, 2024 | 140.00 | 142.79 | 130.05 | 130.63 | 2.231M |
| May 01, 2024 | 127.06 | 131.61 | 127.00 | 130.90 | 1.189M |
| Apr 30, 2024 | 128.65 | 129.70 | 126.53 | 126.66 | 1.093M |
| Apr 29, 2024 | 129.02 | 131.80 | 127.47 | 128.80 | 1.035M |
| Apr 26, 2024 | 127.53 | 131.46 | 125.62 | 128.77 | 1.236M |
| Apr 25, 2024 | 123.00 | 130.61 | 121.80 | 127.39 | 1.694M |
| Apr 24, 2024 | 117.66 | 125.13 | 117.21 | 124.25 | 1.500M |
| Apr 23, 2024 | 117.50 | 119.91 | 117.06 | 117.12 | 568912.0 |
| Apr 22, 2024 | 116.63 | 118.43 | 114.48 | 116.96 | 889164.0 |
| Apr 19, 2024 | 116.55 | 117.74 | 114.37 | 115.62 | 641236.0 |
| Apr 18, 2024 | 117.55 | 118.90 | 115.79 | 116.55 | 498572.0 |
| Apr 17, 2024 | 117.00 | 119.08 | 115.93 | 117.89 | 546229.0 |
| Apr 16, 2024 | 117.60 | 118.69 | 116.94 | 117.29 | 592917.0 |
| Apr 15, 2024 | 122.18 | 122.98 | 117.78 | 118.31 | 860486.0 |
| Apr 12, 2024 | 124.17 | 124.82 | 121.49 | 122.87 | 656117.0 |
| Apr 11, 2024 | 127.28 | 127.49 | 123.40 | 124.45 | 618223.0 |
| Apr 10, 2024 | 124.13 | 126.47 | 123.87 | 126.31 | 523340.0 |
| Apr 09, 2024 | 126.46 | 127.41 | 126.07 | 126.98 | 286092.0 |
| Apr 08, 2024 | 126.17 | 126.68 | 124.37 | 126.39 | 559199.0 |
| Apr 05, 2024 | 125.43 | 127.64 | 123.85 | 126.08 | 303511.0 |
| Apr 04, 2024 | 127.22 | 128.23 | 124.87 | 125.79 | 747118.0 |
| Apr 03, 2024 | 126.07 | 128.60 | 125.17 | 126.92 | 851048.0 |
| Apr 02, 2024 | 127.68 | 128.80 | 125.80 | 127.00 | 519194.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
62.69
Minimum
Jun 16 2022
178.74
Maximum
Dec 22 2020
109.07
Average
111.47
Median
Aug 08 2022
Price Benchmarks
| PTC Therapeutics Inc | 32.98 |
| Amgen Inc | 299.55 |
| Regenxbio Inc | 16.87 |
| Apellis Pharmaceuticals Inc | 48.86 |
| Alnylam Pharmaceuticals Inc | 151.24 |
Price Related Metrics
| PE Ratio | 337.60 |
| PS Ratio | 9.154 |
| Price to Book Value | 13.28 |
| Earnings Yield | 0.30% |
| Market Cap | 12.76B |
| Normalized PE Ratio | 177.33 |